134 related articles for article (PubMed ID: 35242185)
1. lncRNA RUNDC3A-AS1 Regulates Proliferation and Apoptosis of Thyroid Cancer Cells via the miR-151b/SNRPB Axis.
Deng Y; Wu J; Li X
Int J Endocrinol; 2022; 2022():9433434. PubMed ID: 35242185
[TBL] [Abstract][Full Text] [Related]
2. LncRNA ATP1A1-AS1 inhibits cell proliferation and promotes cell apoptosis in thyroid carcinoma by regulating the miR-620/IRF2BP2 axis.
Jia J; Liu Y; Yang X; Wu Z; Xu X; Kang F; Liu Y
Am J Med Sci; 2023 Jan; 365(1):73-83. PubMed ID: 36002076
[TBL] [Abstract][Full Text] [Related]
3. Long Non-coding RNA RUNDC3A-AS1 Promotes Lung Metastasis of Thyroid Cancer via Targeting the miR-182-5p/ADAM9.
Ma D; Zhu Y; Zhang X; Zhang J; Chen W; Chen X; Qian Y; Zhao Y; Hu T; Yao Z; Zhao W; Zhang Y; Liu F
Front Cell Dev Biol; 2021; 9():650004. PubMed ID: 34046406
[TBL] [Abstract][Full Text] [Related]
4. LMCD1 antisense RNA 1 (LMCD1-AS1) potentiates thyroid cancer cell growth and stemness via a positive feedback loop of LMCD1-AS1/miR-1287-5p/GLI2.
Shao J; Xu Y; Li H; Chen L; Wang W; Shen D; Chen J
Ann Transl Med; 2020 Nov; 8(22):1508. PubMed ID: 33313253
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of PAX8-AS1 Inhibits Malignant Phenotypes of Papillary Thyroid Carcinoma Cells via miR-96-5p/PKN2 Axis.
Zhou P; Xu T; Hu H; Hua F
Int J Endocrinol; 2021; 2021():5499963. PubMed ID: 34745257
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.
Huang Y; Ni R; Wang J; Liu Y
Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440
[TBL] [Abstract][Full Text] [Related]
7. LEF-AS1 participates in occurrence of colorectal cancer through adsorbing miR-505 and promoting KIF3B expression.
Gong XY; Huang AL
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9362-9370. PubMed ID: 31773695
[TBL] [Abstract][Full Text] [Related]
8. The knockdown of LncRNA AFAP1-AS1 suppressed cell proliferation, migration, and invasion, and promoted apoptosis by regulating miR-545-3p/hepatoma-derived growth factor axis in lung cancer.
Sun J; Min H; Yu L; Yu G; Shi Y; Sun J
Anticancer Drugs; 2021 Jan; 32(1):11-21. PubMed ID: 33290312
[TBL] [Abstract][Full Text] [Related]
9. LncRNA FOXD2-AS1 knockdown inhibits the resistance of human osteosarcoma cells to cisplatin by inhibiting miR-143 expression.
Zhang QQ; Xu SL; Ding C; Ma CC; Yuan TS; Hua CC; Wang XH
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):678-686. PubMed ID: 33577022
[TBL] [Abstract][Full Text] [Related]
10. NR2F1-AS1 regulated miR-423-5p/SOX12 to promote proliferation and invasion of papillary thyroid carcinoma.
Yang C; Liu Z; Chang X; Xu W; Gong J; Chai F; Cui D
J Cell Biochem; 2020 Feb; 121(2):2009-2018. PubMed ID: 31692033
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of lncRNA FEZF1-AS1 in promoting the occurrence and development of oral squamous cell carcinoma through targeting miR-196a.
Xu L; Hou TJ; Yang P
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6505-6515. PubMed ID: 31378890
[TBL] [Abstract][Full Text] [Related]
12. lncRNA FOXD3-AS1 promotes the progression of non-small cell lung cancer by regulating the miR-135a-5p/CDK6 axis.
Guo H; Lin S; Gan Z; Xie J; Zhou J; Hu M
Oncol Lett; 2021 Dec; 22(6):853. PubMed ID: 34733371
[TBL] [Abstract][Full Text] [Related]
13. LncRNA TTN-AS1 regulates osteosarcoma cell apoptosis and drug resistance via the miR-134-5p/MBTD1 axis.
Fu D; Lu C; Qu X; Li P; Chen K; Shan L; Zhu X
Aging (Albany NY); 2019 Oct; 11(19):8374-8385. PubMed ID: 31600142
[TBL] [Abstract][Full Text] [Related]
14. LncRNA TMPO-AS1 Aggravates the Development of Hepatocellular Carcinoma via miR-429/GOT1 Axis.
Liu X; Shen Z
Am J Med Sci; 2020 Dec; 360(6):711-720. PubMed ID: 32988599
[TBL] [Abstract][Full Text] [Related]
15. LncRNA NNT-AS1 regulates the progression of lung cancer through the NNT-AS1/miR-3666/E2F2 axis.
Huang JW; Luo XY; Li ZH; Lang BP
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):238-248. PubMed ID: 31957837
[TBL] [Abstract][Full Text] [Related]
16. MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway.
Li C; Feng S; Chen L
Mol Cell Biochem; 2021 Feb; 476(2):699-713. PubMed ID: 33106913
[TBL] [Abstract][Full Text] [Related]
17. LncRNA ZEB1-AS1 facilitates ox-LDL-induced damage of HCtAEC cells and the oxidative stress and inflammatory events of THP-1 cells via miR-942/HMGB1 signaling.
Hua Z; Ma K; Liu S; Yue Y; Cao H; Li Z
Life Sci; 2020 Apr; 247():117334. PubMed ID: 31962131
[TBL] [Abstract][Full Text] [Related]
18. The lncRNA SLCO4A1-AS1/miR-876-3p/RBBP6 axis regulates cell proliferation and apoptosis in acute lymphocytic leukemia via the JNK signaling pathway.
Mao J; Gao W; Xue L; Wang J; Zhao L
Int J Lab Hematol; 2021 Oct; 43(5):1050-1061. PubMed ID: 33683013
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA MAFG-AS1 knockdown blocks malignant progression in breast cancer cells by inactivating JAK2/STAT3 signaling pathway via MAFG-AS1/miR-3196/TFAP2A axis.
Ding M; Fu Y; Guo F; Chen H; Fu X; Tan W; Zhang H
Int J Clin Exp Pathol; 2020; 13(10):2455-2473. PubMed ID: 33165437
[TBL] [Abstract][Full Text] [Related]
20. LNCRNA OIP5-AS1 regulates oxidative low-density lipoprotein-mediated endothelial cell injury via miR-320a/LOX1 axis.
Zhang C; Yang H; Li Y; Huo P; Ma P
Mol Cell Biochem; 2020 Apr; 467(1-2):15-25. PubMed ID: 32072428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
